Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The development of a high-plex spatial proteomic methodology for the characterisation of the head and neck tumour microenvironment

ABSTRACT: The development of a high-plex spatial proteomic methodology for the characterisation of the head and neck tumour microenvironment

PROVIDER: PRJNA1217386 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

The development of a high-plex spatial proteomic methodology for the characterisation of the head and neck tumour microenvironment

Project description:Head and neck squamous cell carcinoma (HNSCC) is the seventh most common cancer globally. Despite advancements in treatment modalities, patient prognoses remain unimproved. Insight into the tumour microenvironment (TME) using spatially resolved approaches, and its association with clinical endpoints, may provide useful prognostic tools and refine current treatment outcomes. We profiled 84 mucosal HNSCC tissue samples using next-generation ultra-high plex spatial protein and transcriptome mapping (580-proteins, 18,000 mRNA targets). We found patient survival outcomes (both disease-free and overall survival) were associated with anatomical subsite and tumour stage. We identified proteomic and transcriptomic functional T cell markers within discrete TME regions that were associated with survival. GSEA revealed elevated glycolysis and hypoxia pathways in patients with worse outcomes. Key proteomic findings (including CD34 and CD44) were independently validated using single-cell protein profiling. This study provides a systematic workflow for high-plex protein and transcriptomic profiling in mucosal HNSCC.

2025-06-01 | GSE288406 | GEO

The development of a high-plex spatial proteomic methodology for the characterisation of the head and neck tumour microenvironment (GeoMx WTA)

2025-06-01 | GSE290057 | GEO

The development of a high-plex spatial proteomic methodology for the characterisation of the head and neck tumour microenvironment (GeoMx WTA)

Project description:The development of a high-plex spatial proteomic methodology for the characterisation of the head and neck tumour microenvironment (GeoMx WTA)

| PRJNA1226124 | ENA

Head and neck squamous cell carcinoma

Project description:Quantitative (iTRAQ 4-plex) proteomic analysis of progressive head and neck cancers

2022-03-01 | PXD001438 | Pride

Analysis of B cell neighborhoods via single cell spatial transcriptomics in head and neck cancer patients

Project description:Head and neck squamous cell carcinoma tissue microarrays were stained via CD20 single plex IHC and then FOVs were selected for B cell neighborhoods (including tertiary lymphoid structures) in confirmed tumor areas via H&E evaluation by a pathologist.

2025-01-18 | GSE286935 | GEO

Drug combination sci-Plex Data

Project description:Drug combination sci-Plex Data

| PRJNA851906 | ENA

Feasibility of mass cytometry proteomic characterisation of circulating tumour cells in head and neck squamous cell carcinoma for deep phenotyping.

Project description:BackgroundCirculating tumour cells (CTCs) are a potential cancer biomarker, but current methods of CTC analysis at single-cell resolution are limited. Here, we describe high-dimensional single-cell mass cytometry proteomic analysis of CTCs in HNSCC.MethodsParsortix microfluidic-enriched CTCs from 14 treatment-naïve HNSCC patients were analysed by mass cytometry analysis using 41 antibodies. Immune cell lineage, epithelial-mesenchymal transition (EMT), stemness, proliferation and immune checkpoint expression was assessed alongside phosphorylation status of multiple signalling proteins. Patient-matched tumour gene expression and CTC EMT profiles were compared. Standard bulk CTC RNAseq was performed as a baseline comparator to assess mass cytometry data.ResultsCTCs were detected in 13/14 patients with CTC counts of 2-24 CTCs/ml blood. Unsupervised clustering separated CTCs into epithelial, early EMT and advanced EMT groups that differed in signalling pathway activation state. Patient-specific CTC cluster patterns separated into immune checkpoint low and high groups. Patient tumour and CTC EMT profiles differed. Mass cytometry outperformed bulk RNAseq to detect CTCs and characterise cell phenotype.DiscussionWe demonstrate mass cytometry allows high-plex proteomic characterisation of CTCs at single-cell resolution and identify common CTC sub-groups with potential for novel biomarker development and immune checkpoint inhibitor treatment stratification.

| S-EPMC10645808 | biostudies-literature

6K-plex RNA CosMx data from DLBCL sections.

Project description:6K-plex RNA CosMx data from DLBCL sections.

| PRJNA1221889 | ENA

Assessment of RNA-seq Sample Preparation Methodology

Project description:Assessment of RNA-seq Sample Preparation Methodology

| PRJNA862603 | ENA

Assessment of RNA-seq Sample Preparation Methodology

Project description:Assessment of RNA-seq Sample Preparation Methodology

| PRJNA862601 | ENA